NEW YORK - - As the U.S. Supreme Court prepares to hear a religious dispute over the Obamacare contraception mandate, advocates on both sides are trying to set the court straight on the science.
FRANKFURT - Germany's Bayer said a final stage Phase III clinical trial of cancer drug Nexavar as an adjuvant therapy for liver cancer did not meet its main target.
WASHINGTON - U.S. cancer doctors are worried about their ability to handle an expected surge in cancer cases in the coming years as they face cuts to government health plans and efforts to reduce payments to physicians.
PARIS - French and Belgian drugmakers Sanofi and UCB have entered a partnership aimed at finding treatments for so-called immune-mediated diseases in areas such as rheumatoid arthritis and inflammatory bowel conditions.
DHULIKHEL, Nepal, March 11 (Thomson Reuters Foundation) - Sangita Shrestha desperately waits in a hospital bed to see the baby girl she has just delivered. In the next room, a nurse applies a gel to the stump of the newborn's umbilical cord, wraps her in cloth and places her in a cot next to her mother.
- Germany has granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as 36 percent.
TORONTO - New smartphone apps that link to hearing aids are helping people with impaired hearing to pump up the volume on their devices or to use them as headphones to stream phone calls, YouTube videos and music.
WASHINGTON - The Obama administration, in an abrupt about-face, said on Monday it would drop proposed changes to Medicare drug coverage that met wide opposition on grounds they would harm health benefits for the elderly and disabled.
NEW YORK (Reuters Health) - School children who are bullied are more than twice as likely to think about killing themselves and to make suicide attempts as their peers who aren't bullied, according to a new analysis.
TOKYO/LONDON - A Japanese scientist called on Monday for his own headline-grabbing study on stem cells to be withdrawn from publication, saying its findings had now been thrown into too much doubt.
A series that looks at all facets of cancer, written by Debra Sherman, a stage 4 lung cancer patient. Debra covered the health beat for Reuters for more than a decade and is using her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article